Study adds to growing body of evidence suggesting inhalation of particulate matter from implantation through second trimester is dangerous

The new tools are the first, say the study authors, to identify melanoma DNA in the blood of patients whose cancer is spreading and who lack defects in either the BRAF or NRAS gene

The team’s findings advance the understanding of how the brain processes touch, smell, hearing, sight, and taste

In laboratory experiments, some in human cells and others in mouse cells, researchers found that the process for copying mtDNA (or replication), an essential aspect to energy production, is prone to stalling

The study results address Gaucher's disease, which is caused by a genetic glitch in cell structures called lysosomes that process fats and remove cellular waste

Since its emergence in the 1970s, magnetic resonance imaging (MRI) has given physicians a better look inside tissues, helping to diagnose maladies from brain tumors to internal bleeding to torn ligaments

First quantifiable examination of nutritional quality of food and drink endorsements by music celebrities popular among teens

Research could lead to advanced treatments for social anxiety, post-traumatic stress disorder and other brain behavioral issues

New findings could help with future navigational problems associated with Alzheimer’s and other neurological disorders.

Breakthrough in genetic engineering could advance study of arrhythmias and heart conduction, say researchers at NYU Langone Medical Center.

Developed at NYU Langone Medical Center, the “telomerator” reshapes synthetic yeast chromosome into more flexible, realistic form, redefining what geneticists can build.

New finding could accelerate research to regenerate damaged tissue.

New study suggests bacteria help program metabolic development.

Findings should help narrow the search for genetic contributions of autism and suggest new routes for therapy.

NYU Langone Medical Center has established a new drug discovery accelerator, the Office of Therapeutics Alliances (OTA). OTA is an innovative, nimble program that advances the discovery of novel therapeutic projects by combining the scientific strengths of NYU Langone investigators in dissecting disease pathways with the expertise of external professional drug discovery and development partners in the biopharma industry.